Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 2001;37:604-608

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Diep, Q. N.
Right arrow Articles by Schiffrin, E. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Diep, Q. N.
Right arrow Articles by Schiffrin, E. L.
Related Collections
Right arrow Remodeling

(Hypertension. 2001;37:604.)
© 2001 American Heart Association, Inc.


Scientific Contributions

Expression of Cell Cycle Proteins in Blood Vessels of Angiotensin II–Infused Rats

Role of AT1 Receptors

Quy N. Diep; Mohammed El Mabrouk; Rhian M. Touyz; Ernesto L. Schiffrin

From the Multidisciplinary Research Group on Hypertension, Clinical Research Institute of Montreal, University of Montreal, Quebec, Canada.

Correspondence to Ernesto L. Schiffrin, MD, Clinical Research Institute of Montreal, 110 Pine Ave W, Montreal, Quebec, Canada H2W 1R7. E-mail schiffe{at}IRCM.qc.ca

Angiotensin II is an important modulator of cell growth through AT1 receptors, as demonstrated both in vivo and in vitro. We investigated the role of proteins involved in the cell cycle, including cyclin D1, cyclin-dependent kinase 4 (cdk4), and cyclin-dependent kinase inhibitors p21 and p27 in blood vessels of angiotensin II–infused rats and the effect therein of the AT1-receptor antagonist losartan. Male Sprague-Dawley rats were infused for 7 days with angiotensin II (120 ng/kg per minute SC) and/or treated with losartan (10 mg/kg per day orally). DNA synthesis in mesenteric arteries was evaluated by radiolabeled 3H-thymidine incorporation. The expression of cyclin D1, cdk4, p21, and p27, which play critical roles during the G1-phase of the cell cycle process, was examined by Western blot analysis. Tail-cuff systolic blood pressure (mm Hg) was elevated (P<0.01, n=9) in angiotensin II–infused rats (161.3±8.2) versus control rats (110.1±5.3) and normalized by losartan (104.4±3.2). Radiolabeled 3H-thymidine incorporation (cpm/100 µg DNA) showed that angiotensin II infusion significantly increased DNA synthesis (152±5% versus 102±6% of control rats, P<0.05). Expression of cyclin D1 and cdk4 was significantly increased in the angiotensin II group to 213.7±8% and 263.6±37% of control animals, respectively, whereas expression of p21 and p27 was significantly decreased in the angiotensin II group to 23.2±10.4% and 10.3±5.3% of control animals, respectively. These effects induced by angiotensin II were normalized in the presence of losartan. Thus, when AT1 receptors are stimulated in vivo, DNA synthesis is enhanced in blood vessels by activation of cyclin D1 and cdk4. Reduction in cell cycle kinase inhibitors p21 and p27 may contribute to activation of growth induced by in vivo AT1 receptor stimulation.


Key Words: vasculature • muscle, smooth • hyperplasia • remodeling




This article has been cited by other articles:


Home page
HypertensionHome page
T. Kanda, K. Hayashi, S. Wakino, K. Homma, K. Yoshioka, K. Hasegawa, N. Sugano, S. Tatematsu, I. Takamatsu, T. Mitsuhashi, et al.
Role of Rho-Kinase and p27 in Angiotensin II-Induced Vascular Injury
Hypertension, April 1, 2005; 45(4): 724 - 729.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
G. Wolf and U. O. Wenzel
Angiotensin II and Cell Cycle Regulation
Hypertension, April 1, 2004; 43(4): 693 - 698.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
H. Funke-Kaiser, F. Reichenberger, K. Kopke, S.-M. Herrmann, J. Pfeifer, H.-D. Orzechowski, W. Zidek, M. Paul, and E. Brand
Differential binding of transcription factor E2F-2 to the endothelin-converting enzyme-1b promoter affects blood pressure regulation
Hum. Mol. Genet., February 15, 2003; 12(4): 423 - 433.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
Q. N. Diep, M. El Mabrouk, J. S. Cohn, D. Endemann, F. Amiri, A. Virdis, M. F. Neves, and E. L. Schiffrin
Structure, Endothelial Function, Cell Growth, and Inflammation in Blood Vessels of Angiotensin II-Infused Rats: Role of Peroxisome Proliferator-Activated Receptor-{gamma}
Circulation, May 14, 2002; 105(19): 2296 - 2302.
[Abstract] [Full Text] [PDF]